- Home
- TD vs ABT Comparison
TD vs ABT Comparison
Compare TD & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TD | ABT |
|---|---|---|
| Founded | 1855 | 1888 |
| Country | Canada | United States |
| Employees | 70000 | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 152.8B | 152.9B |
| IPO Year | N/A | 2006 |
Fundamental Metrics
Financial Performance| Metric | TD | ABT |
|---|---|---|
| Price | $113.46 | $85.76 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 20 |
| Target Price | $120.00 | ★ $130.90 |
| AVG Volume (30 Days) | 1.2M | ★ 10.8M |
| Earning Date | 05-21-2026 | 04-16-2026 |
| Dividend Yield | ★ 2.95% | 2.76% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.61 |
| Revenue | N/A | ★ $44,328,000,000.00 |
| Revenue This Year | N/A | $10.75 |
| Revenue Next Year | $4.48 | $8.10 |
| P/E Ratio | ★ $11.65 | $141.38 |
| Revenue Growth | N/A | ★ 5.67 |
| 52 Week Low | $68.99 | $81.97 |
| 52 Week High | $113.51 | $137.49 |
Technical Indicators
Market Signals| Indicator | TD | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 70.36 | 37.99 |
| Support Level | $92.13 | $81.97 |
| Resistance Level | N/A | $89.34 |
| Average True Range (ATR) | 1.67 | 1.84 |
| MACD | 0.23 | 0.59 |
| Stochastic Oscillator | 85.94 | 51.26 |
Price Performance
Historical ComparisonAbout TD Toronto Dominion Bank (The)
Toronto-Dominion is one of Canada's two largest banks with over CAD 2 trillion in assets. TD Bank operates four business segments: Canadian personal and commercial banking, US retail banking, wealth management and insurance, and wholesale banking. The bank derives more than 50% of its revenue from Canada and has dominant market share in nearly all banking products and services. TD has around 44% of its revenue from its US operations. Its US footprint spans from Maine to Florida, with a strong presence in the Northeast.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.